U.S. Physical Therapy, Inc.
USPH
$61.96
-$0.43-0.69%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.35% | 3.70% | |||
| Total Other Revenue | 2.74% | -0.17% | |||
| Total Revenue | -2.34% | 3.04% | |||
| Cost of Revenue | 0.87% | 2.52% | |||
| Gross Profit | -13.68% | 4.94% | |||
| SG&A Expenses | 0.82% | 4.08% | |||
| Depreciation & Amortization | 32.10% | -22.06% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.61% | 1.90% | |||
| Operating Income | -34.52% | 13.35% | |||
| Income Before Tax | -29.38% | -34.61% | |||
| Income Tax Expenses | -58.37% | 10.49% | |||
| Earnings from Continuing Operations | -11.11% | -47.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 37.91% | -11.50% | |||
| Net Income | 21.31% | -68.39% | |||
| EBIT | -34.52% | 13.35% | |||
| EBITDA | -23.39% | 5.53% | |||
| EPS Basic | 71.83% | -190.60% | |||
| Normalized Basic EPS | -38.31% | 24.99% | |||
| EPS Diluted | 71.83% | -190.60% | |||
| Normalized Diluted EPS | -38.31% | 24.99% | |||
| Average Basic Shares Outstanding | 0.00% | -0.24% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.24% | |||
| Dividend Per Share | 2.22% | 0.00% | |||
| Payout Ratio | -- | 2.16% | |||